Bristol-Myers Squibb

Celgene
New York, New York
Pharmaceuticals Biotechnology and Life Sciences

Corporate Bias Rating

Expand Summary

Risk Level:

Rating - Danger
High Risk

Summary:

Bristol Myers Squibb (BMS) is High Risk. The company yields to political activism in shaping corporate governance, potentially alienating consumers, dividing employees, and harming shareholders. The company implements race and identity-based policies that replace merit, excellence, and integrity with preferential treatment and outcomes. BMS embraces corporate initiatives that redirect its central focus from business goals to partisan policies and divisive issues. This approach fails to safeguard free exercise, free speech, and free enterprise.

View Full Corporate Bias Ratings Report

Board Bias

Expand Summary

CEO of Bristol-Myers Squibb

Chris Boerner, Ph.D.

Chris Boerner, Ph.D.

Summary:

Headquartered in New York, New York, Bristol-Myers Squibb is a member of the Fortune 250 operating in the Pharmaceuticals Biotechnology and Life Sciences industry. Chris Boerner, Ph.D. and Giovanni Caforio, MD serve as CEO/President and Chairman, respectively, leading the company’s C-suite executive team and the board of directors. Amongst these teams, the collective leadership is responsible for $180,751 to Republican causes and $173,336 to Democratic causes. Under their tenure, Bristol-Myers Squibb currently holds a 'High Risk' risk rating.

View Full Board Bias Report

Political Contributions of Leadership:

$180,751

$173,336

Republican

Democrat

Shareholder Proposals

Expand Summary

Date
ESG Category
Proponent
Summary of ResolutionMgmt RecTotal Vote % in Favor
5/7/24GovernanceJohn CheveddenExecutives to Retain Significant StockAgainst38.53%
5/7/24GovernanceKenneth SteinerIndependent Board ChairmanAgainst31.71%
5/2/23GovernanceKenneth SteinerRequire the Chairman of the Board to be an Independent DirectorAgainst31.80%
5/2/23GovernanceJohn CheveddenReduce the Number of Shares Required to Call a Special MeetingAgainst5.90%
5/2/23SocialNational Center for Public Policy ResearchCommission an Audit Analyzing the Impacts of Diversity, Equity, and Inclusion PoliciesAgainst1.60%
5/3/22GovernanceMercy Investment ServicesIndependent Board ChairAgainst44.58%
5/3/22GovernanceKenneth SteinerSpecial Meetings - Reduce Ownership Req. to 10%Against34.33%
Generate Reports
Clear
Toast